> In both pivotal studies, a statistically significantly greater percentage of subjects experienced their study eyes returning to normal at all time points measured from 60 minutes through 24 hours in the Ryzumvi group compared with placebo.

Thanks, FDA, industry standards, and general statistics education. This means almost nothing.

How much does it help? What fraction of people are helped? Can one still see comfortably in dim light after administration of dilating drops followed by this? Does it also reverse cycloplegia?